New insights into the roles of ReL/NF-κB transcription factors in immune function, hemopoiesis and human disease

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 10, 1999, Pages 1209-1219

  Grossmann, Mathis ^a   Nakamura, Yukio ^a   Grumont, Raelene ^a   Gerondakis, Steve ^a  

^a NONE

Author keywords

Hemopoiesis; Immune function; NF B; Rel; Transcription

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLOSPORIN; CYTOKINE; GLUCOCORTICOID; HEMOPOIETIC GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOSUPPRESSIVE AGENT; ONCOPROTEIN; TACROLIMUS; TRANSCRIPTION FACTOR;

APOPTOSIS; CARCINOGENESIS; CELL CYCLE; CELL SURVIVAL; GENE TARGETING; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATORY DISEASE; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032829677     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00068-0     Document Type: Article

References (53)

1. Baeuerle P.A., Baltimore D. NF-κ B: ten years after. Cell. 87:1996;13-20.
2. Baldwin A. Jr. The NF-κ B and I κ B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:1996;649-683.
3. Siebenlist U., Franzoso G., Brown K. Structure, regulation and function of NF-κ B. Annu. Rev. Cell. Biol. 10:1994;405-455.
4. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., Miyamoto S. Rel/NF-κ B/I κ B family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.
5. Sha W.C. Regulation of immune responses by NF-κ B/Rel transcription factor. J. Exp. Med. 187:1998;143-146. [published erratum appears in J Exp Med 1998 Feb 16;187(4):661].
6. May M.J., Ghosh S. Signal transduction through NF-κ B. Immunol. Today. 19:1998;80-88.
7. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature. 388:1997;548-554. [see comments].
8. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science. 278:1997;860-866. [see comments].
9. Regnier C.H., Song H.Y., Gao X., Goeddel D.V., Cao Z., Rothe M. Identification and characterization of an IκB kinase. Cell. 90:1997;373-383.
10. Woronicz J.D., Gao X., Cao Z., Rothe M., Goeddel D.V. IκB kinase-beta: NF-κB activation and complex formation with IκB kinase-alpha and NIK. Science. 278:1997;866-869. [see comments].
11. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 91:1997;243-252.
12. Zandi E., Chen Y., Karin M. Direct phosphorylation of IκB by IKKα and IKKβ: discrimination between free and NF-κB-bound substrate. Science. 281:1998;1360-1363.
13. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature. 395:1998;297-300. [see comments].
14. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell. 93:1998;1231-1240.
15. Cohen L., Henzel W.J., Baeuerle P.A. IKAP is a scaffold protein of the IκB kinase complex. Nature. 395:1998;292-296. [see comments].
16. Baeuerle P.A., Henkel T. Function and activation of NF-κ B in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
17. Gerondakis S., Grumont R., Rourke I., Grossmann M. The regulation and roles of Rel/NF-κ B transcription factors during lymphocyte activation. Curr. Opin. Immunol. 10:1998;353-359.
18. Attar R.M., Caamano J., Carrasco D., Iotsova V., Ishikawa H., Ryseck R.P., Weih F., Bravo R. Genetic approaches to study Rel/NF-κ B/I κ B function in mice. Semin. Cancer Biol. 8:1997;93-101.
19. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., Leonardi A., Tran T., Boyce B.F., Siebenlist U. Requirement for NF-κB in osteoclast and B-cell development. Genes Dev. 11:1997;3482-3496.
20. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., Bravo R. Osteopetrosis in mice lacking NF-κB1 and NF-κB2. Nat. Med. 3:1997;1285-1289. [see comments].
21. Horwitz B.H., Scott M.L., Cherry S.R., Bronson R.T., Baltimore D. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells. Immunity. 6:1997;765-772.
22. Beg A.A., Sha W.C., Bronson R.T., Ghosh S., Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κ B. Nature. 376:1995;167-170.
23. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-alpha-induced cell death. Science. 274:1996;782-784. [see comments].
24. Van Antwerp D.J., Martin S.J., Kafri T., Green D.R., Verma I.M. Suppression of TNF-alpha-induced apoptosis by NF-κB. Science. 274:1996;787-789. [see comments].
25. Wang C.Y., Mayo M.W., Baldwin A. Jr. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:1996;784-787. [see comments].
26. Grumont R.J., Rourke I.J., O'Reilly L.A., Strasser A., Miyake K., Sha W., Gerondakis S. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells. J. Exp. Med. 187:1998;663-674.
27. Wu M., Lee H., Bellas R.E., Schauer S.L., Arsura M., Katz D., FitzGerald M.J., Rothstein T.L., Sherr D.H., Sonenshein G.E. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. Embo. J. 15:1996;4682-4690.
28. Abbadie C., Kabrun N., Bouali F., Smardova J., Stehelin D., Vandenbunder B., Enrietto P.J. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:1993;899-912.
29. Jung M., Zhang Y., Lee S., Dritschilo A. Correction of radiation sensitivity in ataxia telangiectasia cells by a truncated I κ B-αa. Science. 268:1995;1619-1621.
30. Wang C.Y., Mayo M.W., Korneluk R.G., Goeddel D.V., Baldwin A. Jr. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c- IAP2 to suppress caspase-8 activation. Science. 281:1998;1680-1683.
31. Wu M.X., Ao Z., Prasad K.V., Wu R., Schlossman S.F. IEX-1L, an apoptosis inhibitor involved in NF-κB-mediated cell survival. Science. 281:1998;998-1001.
32. Sonenshein G.E. Rel/NF-κ B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8:1997;113-119.
33. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., Green D.R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κ B and AP-1. Mol. Cell. 1:1998;543-551.
34. Kwon T.K., Nagel J.E., Buchholz M.A., Nordin A.A. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene. 180:1996;113-120.
35. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc. Natl. Acad. Sci. USA. 94:1997;2927-2932.
36. Perkins N.D., Felzien L.K., Betts J.C., Leung K., Beach D.H., Nabel G.J. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:1997;523-527.
37. Zhong H., Voll R.E., Ghosh S. Phosphorylation of NF-κ B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell. 1:1998;661-671.
38. He J., Choe S., Walker R., Di Marzio P., Morgan D.O., Landau N.R. Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69:1995;6705-6711.
39. Belvin M.P., Anderson K.V. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Ann. Rev. Cell Dev. Biol. 12:1996;393-416.
40. Gerard C. Bacterial infection. For whom the bell tolls. Nature. 395:1998;219. [news; comment].
41. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:1998;284-288. [see comments].
42. Medzhitov R., Preston-Hurlburt P., Janeway C. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397. [see comments].
43. Barnes P.J., Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1997;1066-1071.
44. Baeuerle P.A., Baichwal V.R. NF-κ B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65:1997;111-137.
45. Neurath M.F., Pettersson S., Meyer zum Buschenfelde K.H., Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κ B abrogates established experimental colitis in mice. Nat. Med. 2:1996;998-1004.
46. Luque I., Gelinas C. Rel/NF-κ B and I κ B factors in oncogenesis. Semin. Cancer Biol. 8:1997;103-111.
47. Mayo M.W., Wang C.Y., Cogswell P.C., Rogers-Graham K.S., Lowe S.W., Der C.J., Baldwin A. Jr. Requirement of NF-κB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science. 278:1997;1812-1815.
48. Reuther J.Y., Reuther G.W., Cortez D., Pendergast A.M., Baldwin A. Jr. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev. 12:1998;968-981.
49. Bargou R.C., Emmerich F., Krappmann D., Bommert K., Mapara M.Y., Arnold W., Royer H.D., Grinstein E., Greiner A., Scheidereit C., Dorken B. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100:1997;2961-2969.
50. Sovak M.A., Bellas R.E., Kim D.W., Zanieski G.J., Rogers A.E., Traish A.M., Sonenshein G.E. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100:1997;2952-2960.
51. M Grossman, D. Metcalf, J. Merryfull, A. Beg, D. Baltimore, S. Gerondakis, The combined absence of the transcription factors Ral and Rel A leads to mutiple hemopoietic all defects, Proc, Natl. Acad. Sci. USA, in press.
52. Pohl et al. (1999) (submitted for publication).
53. -/- double knockout mice. J. Exp. Med. 185:1997;1359-1370.